Results 71 to 80 of about 9,146 (212)

Predictors of long‐term outcome in open spina bifida

open access: yes
Developmental Medicine &Child Neurology, Volume 68, Issue 9, Page 1178-1179, September 2026.
Alison Poulton, Pippa Oakeshott
wiley   +1 more source

Prenatal Evaluation of Myelomeningocele: A Neurosurgical Perspective

open access: yes, 2016
Myelomeningocele is a neural tube defect that can be diagnosed in utero. The standard of care is postnatal surgery for repair of the open spinal defect, although prenatal surgery is now offered in some institutions.
Grant, Gerald A.   +2 more
core   +1 more source

Postnatal Management and Outcomes of Hydrocephalus in Patients with Myelomeningocele: a Retrospective Study from a Single Institution

open access: yesHamidiye Medical Journal
Background: This study aims to analyze retrospectively the incidence and management of hydrocephalus in patients with myelomeningocele (MMC) treated at the Gülhane Training and Research Hospital between 2017 and 2022.
Gardashkhan Karımzada   +3 more
doaj   +1 more source

Isolation, characterization, and differentiation of multipotent neural progenitor cells from human cerebrospinal fluid in fetal cystic myelomeningocele

open access: yesStem Cell Research, 2017
Despite benefits of prenatal in utero repair of myelomeningocele, a severe type of spina bifida aperta, many of these patients will still suffer mild to severe impairment. One potential source of stem cells for new regenerative medicine-based therapeutic
Mario Marotta   +9 more
doaj   +1 more source

J Neurosurg Pediatr [PDF]

open access: yes
OBJECTIVEHydrocephalus is common among children with myelomeningocele and is most frequently treated with a ventriculoperitoneal shunt (VPS). Although much is known about factors related to first shunt failure, relatively less data are available about ...

core  

Current views on fetal surgical treatment of myelomeningocele — the Management of Myelomeningocele Study (MOMS) trial and Polish clinical experience [PDF]

open access: yes, 2017
Myelomeningocele (MMC) is the most frequent congenital defect of the central nervous system for which there is no satisfactory alternative to postnatal treatment.
Zamłyński, Jacek; Medical University of Silesia Poland   +8 more
core   +4 more sources

Prenatal folic acid use associated with decreased risk of myelomeningocele: A case-control study offers further support for folic acid fortification in Bangladesh.

open access: yesPLoS ONE, 2017
Neural tube defects contribute to severe morbidity and mortality in children and adults; however, they are largely preventable through maternal intake of folic acid before and during early pregnancy.
Vijaya Kancherla   +7 more
doaj   +1 more source

Maternal laparotomy to fetoscopic myelomeningocele repair in patients with Class 2 obesity is safe and feasible

open access: yesPregnancy
Background There is minimal to no data on fetal surgery outcomes in the setting of body mass index (BMI) ≥ 35. Theoretical concerns exist for increased maternal risks from surgery and increased surgical difficulty due to maternal body habitus.
Braxton Forde   +10 more
doaj   +1 more source

Prenatal intervention for urinary obstruction and myelomeningocele

open access: yes, 2017
Widespread use of ultrasonography has resulted in an increase in the recognition of fetal hydronephrosis. The enthusiasm that accompanied early interventions has been tempered by the experience and results obtained over the past 2 decades.
Baskin, Laurence   +2 more
core  

Relationship of antioxidant enzyme activities with myelomeningocele

open access: yes, 2011
AIM: To investigate the role of erythrocyte free radical scavenging enzyme activities (FRSE), carbonic anhydrase (CA) activity and malondialdehyde (MDA) in infants with myelomeningocele (MM)
DEMIR, Ismail   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy